The American Academy of Pediatrics has approved the Childhood and Adolescent Immunization Schedule for 2024, which has introduced new additions and some exclusions to the vaccination regime. The statement was published in the December issue of Pediatrics and has included newer drugs approved by the FDA. Key additions are nirsevimab, a monoclonal an
461 Reached1 Likes
Acute Renal Failure in Child Due to High Dose of Indomethacin
685 Reached6 Comments
Woman presented with Fever of Unknown Origin
7733 Reached93 Comments19 Likes
Fremanezumab for Prevention and Treatment of Migraine
390 Reached13 Comments11 Likes
Rubella Syndrome in Neonate
1402 Reached12 Comments9 Likes
Case of Adolescent with Severe Macrocytic Anaemia
52948 Reached501 Comments51 Likes